瘤微环境中的前列腺素E2,一个由EP受体2和4调解的复杂事件
Ana Santiso1, Akos Heinemann1, Julia Kargl2
1Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
前列腺素E2 (PGE2) 通过抑制抗瘤免疫力来促进癌症. 向PGE2受体EP2和EP4为新型癌症免疫疗法提供了潜力,特别是当与现有治疗相结合时.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 前列腺素E2 (PGE2) 是一种信号分子,与各种固体瘤癌症进展有关.
- 增高的内PGE2水平和其代谢酶的过度表达与瘤的发展有关.
- PGE2直接影响瘤细胞和血管生成,促进瘤生长.
研究的目的:
- 审查PGE2在瘤微环境的免疫系统中的确定的作用.
- 突出PGE2受体,特别是EP2和EP4作为治疗点的重要性.
- 探索在癌症免疫治疗中准PGE2通路的潜力.
主要方法:
- 对研究PGE2在癌症中的功能进行的文献综述.
- 对PGE2对瘤免疫力的影响研究的分析.
- 对PGE2受体抗剂的临床前和临床数据的检查.
主要成果:
- PGE2显著抑制抗瘤免疫反应,这是癌症发生的关键机制.
- EP2和EP4受体被确定为PGE2免疫抑制作用的关键调解者.
- PGE2受体对抗剂在恢复抗瘤免疫力方面表现有前途.
结论:
- 针对PGE2信号,特别是通过EP2和EP4抗剂,为癌症治疗提供了一个可行的策略.
- 与PGE2受体抗剂和免疫检查点抑制剂的联合治疗可能会提高治疗疗效.
- 通过抑制PGE2调节瘤微环境的免疫反应可以改善患者的治疗结果.
更多相关视频
06:36A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
相关概念视频
Mitogens and the Cell Cycle
The Tumor Microenvironment
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
